Search

Drugs that are already approved by the U.S. Food and Drug Administration (FDA) could hold promise in fighting the new infection known as coronavirus disease 2019 (COVID-19)...

A once-daily combination treatment for those with uncontrolled Type 2 diabetes amplifies the treatment’s effects – lowering both weight and the number of hypoglycemic events, and improving quality of life and glucose control ¬– and makes participants more likely to adhere to their medications.

Artificial intelligence may soon play a critical role in choosing which depression therapy is best for patients.

A new report from cardiologists at UT Southwestern raises the hope that doctors will be able to visually check the jugular venous pressure of heart failure patients remotely, using the camera on a smartphone.

Despite the high number of confirmed cases, the true prevalence of COVID-19 infections is believed to be underestimated due to insufficient testing capacity and a high percentage of asymptomatic people.

A combination of immunotherapy agents that encourages some immune cells to eat cancer cells and alert others to attack tumors put mice with a deadly type of brain cancer called glioblastoma into long-term remission

A new cooling insole developed by UT Southwestern scientists reduced the foot temperature of patients with diabetic neuropathy by several degrees, diminishing a significant risk factor for diabetic foot ulcers.

An experimental drug already shown to be safe and help some patients with clear cell renal cell carcinoma, a deadly form of kidney cancer, effectively disables its molecular target.

A protein produced by the human immune system can potently inhibit several coronaviruses, including the one behind the current COVID-19 outbreak, an international team of investigators reports today.

When Haley and Zachary Sanders had their first baby, Rowan, and learned she had multiple heart defects, they were shattered. They never imagined technology borrowed from video games would help save their baby’s life.